Saemann L, Maier S, Rosner L, Kohl M, Schmucker C, Scherer C
J Extra Corpor Technol. 2023; 54(3):191-202.
PMID: 36742214
PMC: 9891490.
DOI: 10.1182/ject-191-202.
Arrivi A, Barilla F, Carnevale R, Sordi M, Pucci G, Tanzilli G
Cells. 2022; 11(24).
PMID: 36552727
PMC: 9777519.
DOI: 10.3390/cells11243964.
Khosravi M, Kahrom M, Tahari M, Alizadeh K, Soltani G, Ghanad M
J Tehran Heart Cent. 2020; 14(4):177-182.
PMID: 32461758
PMC: 7231684.
Houang E, Bartos J, Hackel B, Lodge T, Yannopoulos D, Bates F
JACC Basic Transl Sci. 2019; 4(2):275-287.
PMID: 31061929
PMC: 6488758.
DOI: 10.1016/j.jacbts.2019.01.009.
Curran J, Burkhoff D, Kloner R
J Cardiovasc Transl Res. 2019; 12(2):95-106.
PMID: 30671717
PMC: 6497619.
DOI: 10.1007/s12265-019-9863-z.
Ischemic Conditioning and Atrial Fibrillation: Hope for a NewTherapy?.
Schmitt H, Liang B, Pickett C
J Atr Fibrillation. 2017; 5(6):753.
PMID: 28496825
PMC: 5153171.
DOI: 10.4022/jafib.753.
Ischaemic conditioning and reperfusion injury.
Hausenloy D, Yellon D
Nat Rev Cardiol. 2016; 13(4):193-209.
PMID: 26843289
DOI: 10.1038/nrcardio.2016.5.
A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest.
Pollock J, Hollenbeck R, Wang L, Janz D, Rice T, McPherson J
Resuscitation. 2013; 85(1):99-103.
PMID: 24036406
PMC: 3905108.
DOI: 10.1016/j.resuscitation.2013.08.275.
Myocardial ischemia-reperfusion injury: a neglected therapeutic target.
Hausenloy D, Yellon D
J Clin Invest. 2013; 123(1):92-100.
PMID: 23281415
PMC: 3533275.
DOI: 10.1172/JCI62874.
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation.
Vassalli G, Milano G, Moccetti T
J Transplant. 2012; 2012:928954.
PMID: 22530110
PMC: 3316985.
DOI: 10.1155/2012/928954.
Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury.
Yin X, Zheng Y, Zhai X, Zhao X, Cai L
Exp Diabetes Res. 2011; 2012:198048.
PMID: 21822424
PMC: 3148591.
DOI: 10.1155/2012/198048.
The therapeutic potential of ischemic conditioning: an update.
Hausenloy D, Yellon D
Nat Rev Cardiol. 2011; 8(11):619-29.
PMID: 21691310
DOI: 10.1038/nrcardio.2011.85.
Morphine postconditioning attenuates ICAM-1 expression on endothelial cells.
Min T, Kim J, Kim J, Noh K, Kim T, Kim W
J Korean Med Sci. 2011; 26(2):290-6.
PMID: 21286024
PMC: 3031017.
DOI: 10.3346/jkms.2011.26.2.290.
Mitochondrial and cell-surface F0F1ATPsynthase in innate and acquired cardioprotection.
Lippe G, Bisetto E, Comelli M, Contessi S, Di Pancrazio F, Mavelli I
J Bioenerg Biomembr. 2009; 41(2):151-7.
PMID: 19387805
DOI: 10.1007/s10863-009-9208-8.
Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.
Suleiman M, Zacharowski K, Angelini G
Br J Pharmacol. 2007; 153(1):21-33.
PMID: 17952108
PMC: 2199383.
DOI: 10.1038/sj.bjp.0707526.
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
Hausenloy D, Yellon D
Heart Fail Rev. 2007; 12(3-4):217-34.
PMID: 17541822
DOI: 10.1007/s10741-007-9026-1.
Connexin 43 in ischemic pre- and postconditioning.
Schulz R, Boengler K, Totzeck A, Luo Y, Garcia-Dorado D, Heusch G
Heart Fail Rev. 2007; 12(3-4):261-6.
PMID: 17516165
DOI: 10.1007/s10741-007-9032-3.
Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling?.
Pantos C, Xinaris C, Mourouzis I, Malliopoulou V, Kardami E, Cokkinos D
Mol Cell Biochem. 2006; 297(1-2):65-72.
PMID: 17024559
DOI: 10.1007/s11010-006-9323-3.
